Market Place
Sourcing Support
Aquavit files IND for Dermatox Phase II/III study
01 May 2023 //
CIINICAL TRIALS ARENA
Aquavit Files Investigational NDA for Intradermal Injection of Botulinum Toxin
28 Apr 2023 //
PR NEWSWIRE
Aquavit Files Two IND`s For Its Botulinum Toxin With FDA
17 Mar 2023 //
PR NEWSWIRE
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
24 Mar 2022 //
PRNEWSWIRE
Aquavit Further Prevails Against Counterfeiters in U.S.
21 Mar 2022 //
PRNEWSWIRE
Aquavit`s AQV-1122 COVID-19 Vaccine Patent Approval Fast Tracked by USPTO
01 Sep 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.